Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia

COVID‐19 (coronavirus disease 2019) represents a pandemic, and several vaccines have been produced to prevent infection and/or severe sequelae associated with SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) infection. There have been several reports of infrequent post vaccine associated...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of laboratory hematology Ročník 43; číslo 4; s. 559 - 570
Hlavní autor:	Favaloro, Emmanuel J.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Chichester Wiley Subscription Services, Inc 01.08.2021 John Wiley and Sons Inc
Témata:	Antibodies Complications Coronaviruses COVID-19 COVID-19 vaccines Enzyme-linked immunosorbent assay Fibrinogen Heparin Idiopathic thrombocytopenic purpura Immunology Laboratories laboratory testing Pandemics Platelet factor 4 platelet factor 4 antibodies Platelets Review Reviews Severe acute respiratory syndrome coronavirus 2 Thrombocytopenia Thrombosis thrombosis with thrombocytopenia syndrome Vaccines vaccine‐associated thrombotic thrombocytopenia vaccine‐induced (immune) thrombotic thrombocytopenia
ISSN:	1751-5521, 1751-553X, 1751-553X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!